baber/WOPTO huggingface dataset:
Patent ES-2300248-T3 (ES)
Title: Dispositivo para la aplicacion de un producto sobre las pestañas o las cejas.
Inventor: GUERET JEAN-LOUIS
IPC: B65D51/32
Filed: 2000-07-21
Granted: 2008-06-16
Abstract: Dispositivo para la aplicación de un producto sobre las pestañas o las cejas, que comprende un vástago (8) y un elemento de aplicación (9) en un extremo del vástago, comprendiendo dicho elemento de aplicación una base (12; 52; 62; 72; 101; 423; 433; 443; 453; 463; 473; 483; 493; 503; 513) de forma alargada y al menos dos elementos en resalte, caracterizado porque los al menos dos elementos en resalte se unen cada uno a la base según un eje que se extiende en la prolongación de un lado correspondiente de la base cuando ésta presenta una sección transversal poligonal o que se extiende tangencialmente a la base cuando ésta presenta una sección transversal no poligonal, y porque dos elementos en resalte al menos se extienden hacia el exterior desde unos lados diferentes de la base, en unas direcciones diferentes, en el caso en que la base presenta una sección transversal poligonal.
Patent ES-2267485-T3 (ES)
Inventor: ASIKAINEN PENTTI
IPC: G01G23/01
Filed: 2000-09-11
Granted: 2007-03-16
Abstract: The invention relates to a method and an arrangement for processing and comparing weighing results, wherein weighing signals are transferred to a data processing unit and which data processing unit is used for further processing the measurement results. One method of the invention for processing and comparing weighing results comprises using the calibration settings, calibration program block and/or calculation program for measurement results of at least done sensor for calculating a proof total by means of a data processing unit, e.g. calibration software or calculation software (120) for measurement results, storing a proof total (130), and comparing changes made and/or randomly occurring in the proof total either with prior theoretical and/or preset proof totals (140). In addition, it is possible to determine a figure of merit from weight measurement samples, measurement-disturbing quantities, measurement results for disturbing quantities, and/or from combinations of the above. The present inventive method and arrangement can be used for avoiding the acquisition of expensive and impractical scales instruments. In addition, the weighing results improve in terms of reliability, and the information representative of weighing results and reliability thereof can be processed in a more flexible manner in various data systems. This reduces the logistic efforts associated with recording and documenting various weighing results.  <IMAGE>
Patent ES-2206191-T3 (ES)
Title: Inhibidores de alta afinidad para validacion de dianas y usos de los mismos.
Inventor: SHOKAT KEVAN M
IPC: G01N33/50
Filed: 2000-01-11
Granted: 2004-05-16
Abstract: Un inhibidor de proteína quinasa de la siguiente fórmula I: en la que R es un 1¿-naftilo, 2¿-naftilo, m-fenoxifenilo, m- benciloxifenilo, m-(2¿, 6¿-dicloro)benciloxifenilo, 3- piperonilo, 1¿-naftilmetilo, 1¿-naftoximetilo o 2¿- naftilmetilo.
Patent ES-2181654-T3 (ES)
Title: Disposicion para refrigerar un subconjunto electrico y aparato tecnico
Inventor: REECK GUIDO
IPC: H05K9/00
Filed: 2000-04-07
Granted: 2003-03-01
Abstract: Disposición para la refrigeración de un subconjunto eléctrico (BG) colocado en una caja (G), con por lo menos un filtro de membrana (MB) colocado respectivamente en una entrada de aire (LE) de la caja (G) para un filtrado a través de su superficie de por lo menos partículas de suciedad del aire que penetra para la refrigeración del subconjunto eléctrico (BG), y con por lo menos un dispositivo de refrigeración (VE) para formar una corriente de aire en la caja (G) y para la salida del aire de refrigeración filtrado y calentado a causa de su paso a través del subconjunto (BG) y/o en circulación alrededor del mismo desde por lo menos una salida de aire (LA) de la caja (G), caracterizada porque el filtro de membrana (MB) está realizado como membrana (MBR) de poros finos colocada sobre un material de soporte (TM) y fabricada de un material conductor eléctrico para el blindaje electromagnético del subconjunto eléctrico (BG).
Patent ES-2351088-T3 (ES)
Title: Filtrado de material protegido.
Inventor: EPSTEIN MICHAEL
IPC: G06F12/14
Filed: 2000-04-25
Granted: 2011-01-31
Abstract: Procedimiento para filtrar (200) material (101) de contenido que facilita un enfoque por fases hacia una seguridad mejorada que comprende: comprobar (110) el material (101) de contenido en cuanto a su conformidad con una norma de protección contra copias para identificar material (311) de contenido autorizado, caracterizado porque comprende además determinar (220) un indicador de mejora que está asociado con el material (311) de contenido autorizado, determinar un estado de mejora de código de programación que está asociado con este procedimiento para filtrar (200) material (101) de contenido, y procesar (120) el material (311) de contenido autorizado sólo cuando el estado de mejora corresponde a o está a un estado más alto que el indicador de mejora.
Patent ES-2184714-T3 (ES)
Title: Producto alimenticio que comprende una masa solida a base de chocolate o analogo en contacto con masa humeda.
Inventor: RABAULT JEAN-LUC
IPC: A23G3/40
Filed: 2000-05-19
Granted: 2003-04-16
Abstract: Producto alimenticio que comprende una masa sustancialmente sólida a base de chocolate o análogo de chocolate en contacto con un medio húmedo en estado no helado, con un contenido en agua libre local comprendido entre 45 % y 88 %, presentando dicha masa sustancialmente sólida una débil reabsorción de agua en las condiciones de conservación apropiada, caracterizada porque la masa sustancialmente sólida de chocolate o análogo de chocolate comprende en porcentaje en peso: - materia grasa 43 a 80 %. - cacao seco y desgrasado < 18 % - leche en polvo descremada < 17 % - AZúCARES > 13 % siendo la proporción en peso cacao seco y desgrasado/(azúcares y eventualmente leche en polvo descremada) inferior a 0, 45 y siendo la masa sólida tal que para un medio húmedo que presenta un contenido en agua libre local comprendido entre 45 y 88 %, la magnitud (rr) es inferior a 3, siendo la magnitud T definida por la igualdad (1): -r= (-[agua] + 0, 37) x MG + (5, 25 x [agua]-1, 67) x (S + PLE) + (26, 2 x [agua]-9, 6) x C + (61 x [agua]-14, 5) x (S + PLE) x C con: - [agua] es el contenido en agua libre local de la fase húmeda en contacto (en g/g), - MG es el contenido en materias grasas del chocolate o equivalente (en g/g), - S + PLE es el contenido en azúcares + leche descremada en polvo del chocolate o equivalente (en g/g), - C es el contenido en cacao seco y desgrasado del chocolate o equivalente (en g/g).
Patent ES-2265955-T3 (ES)
Inventor: GUIDOT GILBERT
IPC: C07C209/62
Filed: 2000-07-04
Granted: 2007-03-01
Abstract: The invention concerns a method for treating an aryl carbamoyl fluoride, comprising in its molecule at least a perhalogenated aliphatic carbon, which bears at least a halogen atom to be exchanged with the fluorine. The method comprises a step which consists in contacting said carbamoyl fluoride with hydrofluoric acid, the hydrofluoric acid/carbamoyl fluoride ratio being maintained during the reaction at a value less than 4, preferably 5. The invention is characterised in that said ratio is not more than 11. The invention is applicable to organic synthesis.
Patent ES-2211583-T3 (ES)
Inventor: WEAVER PAUL C
IPC: A61B17/80
Filed: 2000-09-06
Granted: 2004-07-16
Abstract: The present invention relates to a bone plating system and method for fracture fixation of bone. The bone plating system includes a bone plate, at least one locking screw, and at least one non-locking screw. The bone plate has locking holes with threads and non-locking holes. The locking screws have a shaft with a thread for engaging bone and a head with a thread configured and dimensioned to mate with the thread of the locking holes. The non-locking screws have a thread for engaging bone and a non-threaded head. Both the locking and non-locking screws remain seated in their respective holes for substantially as long as the bone plate is implanted. The non-locking screws compress the bone plate against the bone and hold fracture reduction while the locking screws are secured to the plate at a fixed angular relationship. The mixed fixation achieved by this bone plating system and method is particularly useful for treatment of per-articular fractures.
Patent ES-2219402-T3 (ES)
Inventor: EXNER HUBERTUS
IPC: B07B13/07
Filed: 2000-09-20
Granted: 2004-12-01
Abstract: The invention relates to a sorting device for particles (P) of differing sizes, comprising at least two conveying units (1, 2, 3), whereby the particles which are to be sorted are fed upstream to said units. A height gradation (H) of the planes of conveyance is provided between at least two conveyor units that are arranged successively in the direction of conveyance (X), creating a horizontal space or gap therebetween. The products, for example, which have been transported by conveyer units placed upstream, tip over the end of the upstream conveyor unit and fall onto the downstream conveyor unit.
Patent ES-2304999-T3 (ES)
Inventor: NOLDUS ROGIER AUGUST
IPC: H04Q3/00
Filed: 2000-12-18
Granted: 2008-11-01
Abstract: A telecommunication system for transferring telephone calls and/or data between a first terminal and at least one second terminal, comprising: a telecommunication network for the transfer of the telephone calls and/or the data; an Intelligent Network (IN) control unit, coupled to the telecommunication network for providing Intelligent Network services in the telecommunication network; and a message server unit, coupled to the telecommunication network for receiving a first message from one of the terminals and for sending a second message to at least one of the terminals. The IN control unit is adapted to send the first message to the message server unit and/or to receive the second message from the message server unit. The invention further relates to a method for transferring information in such telecommunication system, from the IN control unit to at least one of the terminals and vice versa, and the invention relates to the use of the first and the second message in such telecommunication system.
Patent ES-2261288-T3 (ES)
Title: Turbina de gas.
Inventor: TIEMANN PETER
IPC: F01D25/24
Filed: 2001-03-26
Granted: 2006-11-16
Abstract: Una turbina de gas (5) con una cámara de combustión principal (10), un sistema de refrigeración para la refrigeración del aire de, al menos, los álabes fijos (26, 29) y los anillos-guía (28, 38) de diferentes fases (25, 27) de la turbina de gas (5) y/o un canal de gas principal, donde se sitúa otra cámara ulterior de combustión (34) en la dirección principal del gas caliente (H) detrás de la cámara de combustión principal (10), en la que, para la refrigeración de una fase (25) de la turbina de gas (5) situada antes de la cámara ulterior de combustión (34), se suministra aire de refrigeración (15) utilizado, caracterizada porque la cámara ulterior de combustión (34) muestra un sistema cerrado de refrigeración (35) en el que, para la refrigeración de una fase (25) de la turbina de gas (5) situada delante, se suministra aire de refrigeración (15) previamente utilizado.
Patent ES-2266090-T3 (ES)
Inventor: JACOBS ANTONIUS A C
IPC: C12N5/10
Filed: 2001-12-14
Granted: 2007-03-01
Abstract: The present invention relates i.a. to nucleic acid sequences encoding novel  Lawsonia intracellularis  proteins. It furthermore relates to DNA fragments, recombinant DNA molecules and live recombinant carriers comprising these sequences. Also it relates to host cells comprising such nucleic acid sequences, DNA fragments, recombinant DNA molecules and live recombinant carriers. Moreover, the invention relates to proteins encoded by these nucleotide sequences. The invention also relates to vaccines for combating  Lawsonia intracellularis  infections and methods for the preparation thereof. Finally the invention relates to diagnostic tests for the detection of  Lawsonia intracellularis  DNA, the detection of  Lawsonia intracellularis  antigens and of antibodies against  Lawsonia intracellularis.
Patent ES-2241804-T3 (ES)
Inventor: RUSTING FRANS TEUNIS
IPC: F16L49/02
Filed: 2001-02-23
Granted: 2005-11-01
Abstract: Sealing socket (1) and method for arranging a sealing socket to a tube (2). A sealing socket (1) comprises a sleeve (3) having an outer dimension somewhat larger than the tube (2) to be sealed, defining an annular compartment (4) between the tube (2) and the sleeve (3), in which a gasket (6) is introduced. The gasket material is pressurised by a pressure ring (7) which is permanently connected by welding (8) to the sleeve (3). <IMAGE>
Patent ES-2292578-T3 (ES)
Inventor: HORIUCHI YUKIHARU
IPC: G06K15/16
Filed: 2001-04-19
Granted: 2008-03-16
Abstract: A method of controlling printing on one or a plurality of printing documents on a page basis using a specified sheet size for one page and based on a plurality of combinations of a sheet-feed and a sheet-cut of printing sheets, in printing on printing documents as requested by an application program. When a page mode is in a Form ÄNo cutÜ mode, print image data is prepared so that a sheet-feed is executed at the end of one-page printing (step S503); when in a Form ÄCutÜ mode, print image data is prepared so that a sheet-feed is executed at the end of one-page printing, and a sheet-cut command is issued at the end of the sheet-feed (step S504); when in a Report ÄNo cutÜ mode, print image data is prepared so that a sheet-feed is executed at the end of one-printing-document printing (step S505); and when in a Report ÄCutÜ mode, print image data is prepared so that a sheet-feed is executed at the end of one-printing-document printing, and a sheet-cut command is issued at the end of the sheet-feed (step S506) to complete a page mode-compliant processing. <IMAGE>
Patent ES-2357699-T3 (ES)
Inventor: SANDERS STEVEN
IPC: A61P13/10
Filed: 2001-04-24
Granted: 2011-04-28
Abstract: A pharmaceutical composition that minimises an adverse drug experience associated with oxybutynin therapy comprises oxybutynin, wherein the composition in use provides a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1.
Patent ES-2245694-T3 (ES)
Inventor: PETERS OLAF
IPC: A61P25/28
Filed: 2001-04-12
Granted: 2006-01-16
Abstract: This invention describes the new 8beta-substituted estratrienes of general formula I in which R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>6</SUP>, R<SUP>6'</SUP>, R<SUP>7</SUP>, R<SUP>7'</SUP>, R<SUP>9</SUP>, R<SUP>11</SUP>, R<SUP>11'</SUP>, R<SUP>12</SUP>, R<SUP>14</SUP>, R<SUP>15</SUP>, R<SUP>15'</SUP>, R<SUP>16</SUP>, R<SUP>16'</SUP>, R<SUP>17</SUP>, R<SUP>17'</SUP> have the meanings that are indicated in the description, and R<SUP>8 </SUP>means a straight-chain or branched-chain, optionally partially or completely halogenated alkyl or alkenyl radical with up to 5 carbon atoms, an ethinyl- or prop-1-inyl radical, as pharmaceutical active ingredients that have in vitro a higher affinity to estrogen receptor preparations of rat prostates than to estrogen receptor preparations of rat uteri and in vivo preferably a preferential action on bone rather than the uterus and/or a pronounced action with respect to stimulation of the expression of 5HT2a-receptors and 5HT2a-transporters, their production, their therapeutic use and pharmaceutical dispensing forms that contain the new compounds. The invention also describes the use of these compounds for treatment of estrogen-deficiency-induced diseases and conditions as well as the use of an 8beta-substituted estratriene structural part in the total structures of compounds that have a dissociation in favor of their estrogenic action on bones rather than the uterus.
Patent ES-2369253-T3 (ES)
Inventor: OKANO TERUO
IPC: A61L27/60
Filed: 2001-07-02
Granted: 2011-11-28
Abstract: Cells are cultured on a cell culture support having a substrate surface coated with a temperature-responsive polymer whose upper or lower critical solution temperature in water is 0¼80°C, optionally forming multiple cultured cell layers by a conventional technique, and subsequently: 
(1) the temperature of the culture solution is brought to above the upper critical solution temperature or below the lower critical solution temperature; 
(2) the cultured epidermal cell sheet or multi-layered skin sheet is brought into close contact with the polymer membrane; and 
(3) the sheet is peeled off together with the polymer membrane. The thus obtained epidermal cultured cell sheet and multi-layered cultured skin sheet do not degrade E-cadherin or laminin 5 as contrasted with Dispase treatment and they still involve very few structural defects; these sheets hence hold great promise in clinical applications such as skin grafting.
Patent ES-2233758-T3 (ES)
Inventor: SASAKI TOYONORI
IPC: B41J2/175
Filed: 2002-09-27
Granted: 2005-06-16
Abstract: An ink cartridge (200) includes an ink-holding portion and a rigid upper surface. The ink-holding portion includes a rigid indented surface portion and a flexible film. The indended surface portion has an open side at one side thereof that is covered by the flexible film. Ink is accommodated between the indented surface portion and the flexible film. The upper surface is positioned opposite from the indented surface portion with respect to the flexible film. The upper surface (212) is formed with a substantial semispherical shape that bulges in a direction away from the indented surface portion. <IMAGE>
Patent ES-2327615-T3 (ES)
Inventor: DELUCA HECTOR F
IPC: C07D413/06
Filed: 2002-02-12
Granted: 2009-11-02
Abstract: Preparation, use, and structure of endogenous Ah receptor ligand is disclosed.
Patent ES-2355895-T3 (ES)
Title: Funcionalidad de presencia en el protocolo h.323.
Inventor: PAVLAK ZDESLAV
IPC: H04L29/08
Filed: 2002-05-24
Granted: 2011-04-01
Abstract: El método para el seguimiento de un estado de registro de uno o más usuarios en una red de comunicación de acuerdo con un estándar H.323, dichos usuarios asociados con un Seleccionador (GK) que administra los registros y las anulaciones de registro de dichos usuarios, cada usuario (1) que accede a la red de comunicación a través de un Punto Final asociado de la red de comunicación, caracterizado por enviar un primer mensaje desde dicho Seleccionador (4) a un Servidor de Aplicaciones de Presencia (PAS) (5), que mantiene una lista de presencia para cada uno de los usuarios, cada vez que uno de los usuarios cambia el estado de registro en la red de comunicación, dicho primer mensaje incluye una identificación de usuario del usuario actual, una identificación del Seleccionador, y el cambio del estado de registro para dicho usuario, devolver, desde dicho PAS (5) a dicho GK (4), un URL que apunta a la lista de presencia de dicho usuario, actualizar aquéllas de dichas listas de presencia afectadas por el cambio del estado de registro de dicho usuario por consiguiente, enviar, desde dicho PAS (5), un segundo mensaje al Seleccionador (4) que informa al Seleccionador (4) sobre la actualización.
Patent ES-2271268-T3 (ES)
Inventor: CALLISTER JEFFERY P
IPC: A61F7/00
Filed: 2002-05-31
Granted: 2007-04-16
Abstract: A catheter system for controlling the body temperature of a patient by modifying the temperature of blood flowing within a blood vessel of the patient. The catheter system comprises a catheter body having a heat exchange region in contact with the blood; and a mechanism for moving the heat exchange surface, thereby increasing heat exchange between the heat exchange surface and blood flowing past the heat exchange surface. Various methods of moving the heat exchange surface are disclosed.
Patent ES-2243763-T3 (ES)
Title: Base libre de clindamicina cristalina.
Inventor: CHAO ROBERT S
IPC: A61P31/04
Filed: 2002-08-26
Granted: 2005-12-01
Abstract: La clindamicina cristalina de la presente invención puede ser usada como una sustancia fármaco en formulaciones farmacéuticas que aprovechan la insolubilidad en agua de la forma de base libre de la clindamicina. Existen diferentes formas cristalinas polimórficas y pseudopolimórficas de la base libre de clindamicina, de las cuales tres han sido identificadas aquí como Formas I, II y III. La Forma I de base libre cristalina de clindamicina se caracteriza por un espectro de difracción de rayos X en polvo sustancialmente como el mostrado en la Figura 1 y por una calorimetría de barrido diferencial que presenta una endoterma que tiene una temperatura de inicio extrapolada de aproximadamente 67ºC, un temperatura pico de aproximadamente 69ºC y un calor asociado de aproximadamente 517 J/g. La Forma II se caracteriza por un espectro de difracción de rayos X en polvo sustancialmente como el mostrado en la Figura 5 y por una calorimetría de barrido diferencial que presenta una endoterma que tiene unatemperatura de inicio extrapolada de aproximadamente 63ºC, una temperatura pico de aproximadamente 75ºC y un calor asociado de aproximadamente 65 J/g. La Forma III se caracteriza por un espectro de difracción de rayos X en polvo sustancialmente como el mostrado en la Figura 9 y por una calorimetría de barrido diferencial que presenta una endoterma que tiene una temperatura de inicio extrapolada de aproximadamente 64ºC, una temperatura pico de aproximadamente 69ºC y un calor asociado de aproximadamente 69 J/g.
Patent ES-2297004-T3 (ES)
Inventor: SASAGAWA MASAHIRO
IPC: C08F8/04
Filed: 2002-10-23
Granted: 2008-05-01
Abstract: Disclosed is a hydrogenated copolymer obtained by hydrogenating an unhydrogenated copolymer comprising conjugated diene monomer units and vinyl aromatic monomer units, the unhydrogenated copolymer having at least one polymer block (H) of vinyl aromatic monomer units, wherein the hydrogenated copolymer has the following characteristics (1) to (5): (1) a content of the vinyl aromatic monomer units of from more than 60% by weight to less than 90 % by weight, based on the weight of the hydrogenated copolymer; (2) a content of the polymer block (H) of from 1 to 40 % by weight, based on the weight of the unhydrogenated copolymer; (3) a weight average molecular weight of from more than 100,000 to 1,000,000; (4) a hydrogenation ratio of 85 % or more, as measured with respect to the double bonds in the conjugated diene monomer units; and (5) substantially no crystallization peak observed at -50 to 100  DEG C in a differential scanning calorimetry (DSC) chart obtained with respect to the hydrogenated copolymer. <IMAGE>
Patent ES-2305300-T3 (ES)
Inventor: DOWLE MICHAEL D
IPC: A61P31/04
Filed: 2002-11-08
Granted: 2008-11-01
Abstract: A method for the prevention of an orthomyxovirus or paramyxovirus infection comprising the step of administration to a subject in need thereof of an effective amount of a compound of formula (I)
Patent ES-2327823-T3 (ES)
Inventor: GAAL JOZSEF
IPC: E01H11/00
Filed: 2002-10-30
Granted: 2009-11-04
Abstract: The subject matter of the invention is a connection arrangement of a weeding machine mounted onto a railway vehicle which is provided with a weed recognising camera, a PC connected to it for recognition of weeds, a meteorological unit, the said units are connected to a control PC. The control PC is connected to a control panel, which in turn is connected to a spraying unit through an electronic control unit and a dosing unit. The spraying unit consists of a water tank, a pump, a flow meter, a control valve, a spraying frame provided with an axle and nozzles furthermore a chemical agent tank, a chemical agent pump and a flow-meter of chemical agent, all the units are connected together. The connection arrangement is containing a species recognising camera connected to a species recognising PC and relief following laser camera connected to a relief following PC and is containing a pre-spraying unit and a spraying unit. The subject matter of the invention is furthermore a procedure for weeding with the above connection arrangement.